EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The role of body composition in left ventricular remodeling, reverse remodeling, and clinical outcomes for heart failure with mildly reduced ejection fraction: more knowledge to the “obesity paradox”

Kang Fu, Youran Dong, Zhiyuan Wang, Junlin Teng, Congyi Cheng, Cong Su, Xiaoping Ji, Huixia Lu

Cardiovascular Diabetology · 2024

DOI: 10.1186/s12933-024-02430-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Diabetology, 2024. Verfasst von Kang Fu und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Innovation and Transformation of Luobing Theory, Jinan, China. Hauptthemen laut MEDLINE: Ventricular Remodeling, Heart Failure, Stroke Volume, Ventricular Function, Left. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Although the "obesity paradox" is comprehensively elucidated in heart failure (HF) with reduced ejection fraction (HFrEF) and HF with preserved ejection fraction (HFpEF), the role of body composition in left ventricular (LV) remodeling, LV reverse remodeling (LVRR), and clinical outcomes is still unclear for HF with mildly reduced ejection fraction (HFmrEF). METHODS: Our study is a single-centre, prospective, and echocardiography-based study. Consecutive HFmrEF patients, defined as HF patients with a left ventricular ejection fraction (LVEF) between 40 and 49%, between January 2016 to December 2021 were included. Echocardiography was re-examined at 3-, 6-, and 12-month follow-up to assess the LVRR dynamically. Body mass index (BMI), fat mass, fat-free mass, percent body fat (PBF), CUN-BAE index, and lean mass index (LMI) were adopted as anthropometric parameters in our study to assess body composition. The primary outcome was LVRR, defined as: (1) a reduction higher than 10% in LV end-diastolic diameter index (LVEDDI), or a LVEDDI < 33 mm/m2, (2) an absolute increase of LVEF higher than 10 points compared with baseline echocardiogram, or a follow-up LVEF ≥50%. The secondary outcome was a composite of re-hospitalization for HF or cardiovascular death. RESULTS: A total of 240 HFmrEF patients were enrolled in our formal analysis. After 1-year follow-up based on echocardiography, 113 (47.1%) patients developed LVRR. Patients with LVRR had higher fat mass (21.7 kg vs. 19.3 kg, P = 0.034) and PBF (28.7% vs. 26.6%, P = 0.047) compared with those without. The negative correlation between anthropometric parameters and baseline LVEDDI was significant (all P < 0.05). HFmrEF patients with higher BMI, fat mass, PBF, CUN-BAE index, and LMI had more pronounced and persistent increase of LVEF and decline in LV mass index (LVMI). Univariable Cox regression analysis revealed that higher BMI (HR 1.042, 95% CI 1.002-1.083, P = 0.037) and fat mass (HR 1.019, 95% CI 1.002-1.036, P = 0.026) were each significantly associated with higher cumulative incidence of LVRR for HFmrEF patients, while this relationship vanished in the adjusted model. Mediation analysis indicated that the association between BMI and fat mass with LVRR was fully mediated by baseline LV dilation. Furthermore, higher fat mass (aHR 0.957, 95% CI 0.917-0.999, P = 0.049) and PBF (aHR 0.963, 95% CI 0.924-0.976, P = 0.043) was independently associated with lower risk of adverse clinical events. CONCLUSIONS: Body composition played an important role in the LVRR and clinical outcomes for HFmrEF. For HFmrEF patients, BMI and fat mass was positively associated with the cumulative incidence of LVRR, while higher fat mass and PBF predicted lower risk of adverse clinical events but not LMI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ventricular RemodelingHeart FailureStroke VolumeVentricular Function, LeftObesityBody CompositionHumansMaleFemaleMiddle AgedAgedProspective StudiesTime FactorsRisk FactorsAdiposityRisk AssessmentBody Mass IndexPrognosisEchocardiography

Stichwörter der Autor:innen

Body compositionHeart failure with mildly reduced ejection fractionLeft ventricular reverse remodeling

Autor:innen und Institutionen

  • State Key Laboratory for Innovation and Transformation of Luobing Theory, Jinan, China.
  • Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences, Jinan, China.
  • Department of Cardiology, Cheeloo College of Medicine, Qilu Hospital of Shandong University, Shandong University, Jinan, China.
  • State Key Laboratory for Innovation and Transformation of Luobing Theory, Jinan, China. jixiaoping@sdu.edu.cn.
  • Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences, Jinan, China. jixiaoping@sdu.edu.cn.
  • Department of Cardiology, Cheeloo College of Medicine, Qilu Hospital of Shandong University, Shandong University, Jinan, China. jixiaoping@sdu.edu.cn.

Zitieren

APA

Fu, K., Dong, Y., Wang, Z., Teng, J., Cheng, C., Su, C., Ji, X., & Lu, H. (2024). The role of body composition in left ventricular remodeling, reverse remodeling, and clinical outcomes for heart failure with mildly reduced ejection fraction: more knowledge to the “obesity paradox”. Cardiovascular Diabetology. https://doi.org/10.1186/s12933-024-02430-9

Vancouver

Fu K, Dong Y, Wang Z, Teng J, Cheng C, Su C, et al. The role of body composition in left ventricular remodeling, reverse remodeling, and clinical outcomes for heart failure with mildly reduced ejection fraction: more knowledge to the “obesity paradox”. Cardiovascular Diabetology. 2024. doi:10.1186/s12933-024-02430-9

BibTeX
@article{Fu2024,
  author = {Fu, Kang and Dong, Youran and Wang, Zhiyuan and Teng, Junlin and Cheng, Congyi and Su, Cong and Ji, Xiaoping and Lu, Huixia},
  title = {The role of body composition in left ventricular remodeling, reverse remodeling, and clinical outcomes for heart failure with mildly reduced ejection fraction: more knowledge to the “obesity paradox”},
  journal = {Cardiovascular Diabetology},
  year = {2024},
  doi = {10.1186/s12933-024-02430-9}
}
Kostenlos starten →